Dr Yves Fradet graduated from Laval University (Quebec, Canada) in 1981 and completed an oncology fellowship at the Memorial Sloan-Kettering Cancer Center, with Drs Willet Whitmore and Lloyd Old. In 1983 he founded, at the Laval University Cancer Research Center, a translational and clinical research laboratory in urological cancers whose work are supported continuously for more than 30 years.
Dr Fradet still has a very active practice in uro-Oncology within the Urologic Oncology Section and the Urology Service at the CHU de Québec- Hôtel-Dieu de Québec where he has grouped a team of specialists among the most important in Canada including seven uro-oncologists, three of which are also holders of PhD.
He is a member of many national and international societies, including since 2001, the American Association of Genitourinary Surgeons in which he was invited to be part of the 75 members in America. More recently, he was appointed international honorary member of the Association of Academic European Urology, membership awarded to those who have had important influence on urology. Dr Fradet is often invited as a guest speaker at national and international meetings, as a visiting professor, and as a consultant to many organizations. He was the founding chairman of the Canadian Urologic Oncology Group from 1988 to 1995 and chairman of the Department of Surgery at Laval University from 2000 to 2008. He has authored over 330 publications and book chapters and more than 600 abstracts.
1401, 18e rue
G4.610
Québec, QC
Canada G1J 1Z4
Latest news
- Besançon, MarjorieEmployeeHôpital de l'Enfant-Jésus+1 418-525-4444, extension 67725+1 418-691-5562marjorie.besancon.1@ulaval.camarjorie.besancon@crchudequebec.ulaval.ca
1401, 18e rue
G4.612
Québec, QC
Canada G1J 1Z4 - Bolduc Labrie, ArianeEmployeeariane.bolduc-labrie@crchudequebec.ulaval.ca
- Brisson, HervéEmployeeL'Hôtel-Dieu de Québec+1 418-525-4444, extension 16849+1 418-691-5562herve.brisson@crchudequebec.ulaval.ca
10, McMahon
1875
Québec, Québec
Canada G1R 2J6 - Deroy-Lambert, JoanieEmployeeHôpital de l'Enfant-Jésus+1 418-525-4444, extension 67706Joanie.Deroy-Lambert@crchudequebec.ulaval.ca
1401, 18e rue
G4.617
Québec, QC
Canada G1J 1Z4 - Gagné, ChristineEmployeeHôpital de l'Enfant-Jésus+1 418-525-4444, extension 67709christine.gagne@crchudequebec.ulaval.ca
1401, 18e rue
G4.612
Québec, QC
Canada G1J 1Z4 - Gaignier, FannyEmployeeL'Hôtel-Dieu de Québec+1 418-525-4444, extension 15839+1 418-691-5562fanny.gaignier.1@ulaval.cafanny.gaignier@crchudequebec.ulaval.ca
10, rue McMahon
0880
Québec, Québec
Canada G1R 3S3 - Gérard, CatherineEmployeeHôpital de l'Enfant-Jésus+1 418-525-4444, extension 67704+1 418-691-2958Catherine.Gerard@crchudequebec.ulaval.ca
1401, 18e rue
G4-614
Québec, QC
Canada G1J 1Z4 - Hovington, HélèneEmployeeHôpital de l'Enfant-Jésus+1 418-525-4444, extension 16845+1 418-691-3243Helene.Hovington@crchudequebec.ulaval.ca
1401, 18e rue
G4.615
Québec, QC
Canada G1J 1Z4 - Lachance, CamilleEmployeeHôpital de l'Enfant-Jésus+1 418-525-4444, extension 67708camille.lachance@crchudequebec.ulaval.ca
1401, 18e rue
G4.632
Québec, QC
Canada G1J 1Z4 - Larouche, AudreyEmployeeHôpital de l'Enfant-Jésus+1 418-525-4444, extension 67707audrey.larouche@crchudequebec.ulaval.ca
1401, 18e rue
G4.617
Québec, QC
Canada G1J 1Z4 - Maranda Trahan, Anne-MarieEmployeeHôpital de l'Enfant-Jésus+1 418-525-4444, extension 67705Anne-Marie.Maranda@crchudequebec.ulaval.ca
1401, 18e rue
G4.617
Québec, QC
Canada G1J 1Z4 - Michaud, JulieEmployeeHôpital de l'Enfant-Jésus+1 418-525-4444, extension 67713julie.michaud@crchudequebec.ulaval.ca
1401, 18e rue
G4.634
Québec, QC
Canada G1J 1Z4 - Picard, ValérieEmployeeL'Hôtel-Dieu de Québec+1 418-525-4444, extension 16843+1 418-691-5562Valerie.Picard@crchudequebec.ulaval.ca
10, McMahon
1875
Québec, Québec
Canada G1R 2J6 - Plante, CaroleEmployeeHôpital de l'Enfant-Jésus+1 418-525-4444, extension 67712+1 418-691-2958Carole.Plante@crchudequebec.ulaval.ca
1401, 18e rue
G4.634
Québec, QC
Canada G1J 1Z4 - Rajaobelison, GentianeEmployeeHôpital de l'Enfant-Jésus+1 418-525-4444, extension 67695gentiane.rajaobelison@crchudequebec.ulaval.ca
1401, 18e rue
G4.632
Québec, QC
Canada G1J 1Z4 - Savard, MarilynEmployeeHôpital de l'Enfant-Jésus+1 418-525-4444, extension 67703+1 418-691-3154Marilyn.Savard@crchudequebec.ulaval.ca
1401, 18e rue
G4.615
Québec, QC
Canada G1J 1Z4 - Tremblay, VincentEmployeeL'Hôtel-Dieu de Québec+1 418-525-4444, extension 15221vincent.tremblay@crchudequebec.ulaval.ca
9 rue Mcmahon
3744
Québec, Québec
Canada G1R 3S3 - Tremblay-Boily, MélanieEmployeeHôpital de l'Enfant-Jésus+1 418-525-4444, extension 67702melanie.tremblay-boily@crchudequebec.ulaval.ca
1401, 18e rue
G4.614
Québec, QC
Canada G1J 1Z4 - Veilleux, CélineEmployeeHôpital de l'Enfant-Jésus+1 418-525-4444, extension 67727+1 418-691-5562Celine.Veilleux@crchudequebec.ulaval.ca
1401, 18e rue
G4.663
Québec, QC
Canada G1J 1Z4
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
Journal ArticleLancet Oncol, 23 (3), 2022.
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials
Journal ArticleClin Cancer Res, 28 (10), 2022.
Effects of omega-3 fatty acids supplementation on perioperative blood loss and complications after radical prostatectomy
Journal ArticleClin Nutr ESPEN, 47 , 2022.
Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor-associated macrophage phenotype
Journal ArticleClin Transl Med, 12 (1), 2022.
A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti-PD-1 Resistance through Effects on the Gut Microbiota
Journal ArticleCancer Discov, 12 (4), 2022.
Follicle-stimulating hormone (FSH) levels prior to prostatectomy are not related to long-term oncologic or cardiovascular outcomes for men with prostate cancer
Journal ArticleAsian J Androl, 24 (1), 2022.
Identification of Morphologic Criteria Associated with Biochemical Recurrence in Intraductal Carcinoma of the Prostate
Journal ArticleCancers (Basel), 13 (24), 2021.
Dimensional reduction based on peak fitting of Raman micro spectroscopy data improves detection of prostate cancer in tissue specimens
Journal ArticleJ Biomed Opt, 26 (11), 2021.
Identification of Abundant and Functional dodecaRNAs (doRNAs) Derived from Ribosomal RNA
Journal ArticleInt J Mol Sci, 22 (18), 2021.
18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is accurate for high-grade prostate cancer bone staging when compared to bone scintigraphy
Journal ArticleCan Urol Assoc J, 15 (10), 2021.
Active projects
- En route towards prebiotic clinical trials for enhancement of immunotherapies in bladder and prostate cancers, from 2020-06-01 to 2024-04-30
- Repurposing bicalutamide to improve the response to immune checkpoint inhibition for treatment of advanced urothelial carcinoma, from 2022-08-01 to 2026-07-31
- Targeting sex steroids to improve the response to bladder cancer immunotherapy, from 2021-10-01 to 2026-09-30
- What are my options? A feasibility study of a personalized primary prevention strategy for women and men at high risk of breast and prostate cancer, from 2022-01-15 to 2024-01-14
Recently finished projects
- CQDM_Projet de recherche PICT-01 sur le cancer de la prostate , from 2019-12-01 to 2022-11-30
- Developement of a prostate cancer vaccine, from 2022-07-20 to 2023-07-19
- Impact of lifestyle on gut barrier function, bacterial translocation and risk of prostate cancer, from 2020-09-01 to 2023-04-30
- Intégration de l'imagerie par résonance magnétique multiparamétrique dans la trajectoire diagnostique des patients avec suspicion de cancer de la prostate au CHU de Québec - Université Laval , from 2020-06-15 to 2022-09-30
- Interaction between environment, diet, physical activities, and sexual habits, in the risk of prostate cancer. Validation of biomarkers to personnalize preventive interventions., from 2012-10-01 to 2021-12-31
- Maintien de colonies de souris transgéniques exprimant des molécules de CMH humaines , from 2022-03-22 to 2023-03-21
- Stromal Gene Expression Predicts And May Drive Metastasis in Prostate Cancer, from 2017-04-01 to 2022-03-31
- Testing of Biological Activity of DPX-Survivac in vivo in HLA-A1, HLA-A24 and HLA-B7 Transgenic mice, from 2021-05-28 to 2021-11-27